Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 vistas
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
Mostrar más
Comentarios de Facebook
No se encontraron comentarios